| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.56▼ | 0.56▼ | 0.56▼ | 0.55▼ | 0.51▲ |
| MA10 | 0.56▼ | 0.56▼ | 0.56▼ | 0.52▲ | 0.48▲ |
| MA20 | 0.55▼ | 0.54▲ | 0.53▲ | 0.49▲ | 0.50▲ |
| MA50 | 0.52▲ | 0.50▲ | 0.49▲ | 0.46▲ | 0.52▲ |
| MA100 | 0.49▲ | 0.49▲ | 0.50▲ | 0.50▲ | 0.88▼ |
| MA200 | 0.50▲ | 0.54▼ | 0.56▼ | 0.52▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.003▼ | -0.001▼ | 0.008▲ | 0.012▲ |
| RSI | 50.472▲ | 52.095▲ | 54.164▲ | 56.720▲ | 51.659▲ |
| STOCH | 45.797 | 46.120 | 54.158 | 60.471 | 51.220 |
| WILL %R | -67.290 | -67.290 | -40.299 | -47.988 | -41.250 |
| CCI | -46.032 | -50.023 | -21.100 | 51.660 | 161.466▲ |
|
Tuesday, September 15, 2026 02:34 AM
币界网消息,Impact Biomedical Inc (NYSE: IBO)宣布进行1比12.62的反向股票拆分,以推进与Zoar Limited(前称DR Ashleys Limited)的合并。
|
|
Monday, September 14, 2026 08:29 PM
Impact Biomedical Inc (NYSE: IBO) today announced that the Company's Board of Directors has approved a 1 for 12.62 reverse stock split of the Company's issued ...
|
|
Monday, September 14, 2026 06:27 PM
Impact Biomedical Inc. (NYSE American: IBO) has corrected a previously issued press release to fix an error in the merger exchange ratio related to its proposed combination ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/09/26 | 0.5401 | 0.541 | 0.5401 | 0.541 | 89,777 |
| 21/09/26 | 0.59 | 0.5968 | 0.5501 | 0.5557 | 79,687 |
| 18/09/26 | 0.5714 | 0.59 | 0.5501 | 0.59 | 97,255 |
| 17/09/26 | 0.5218 | 0.61 | 0.5218 | 0.5714 | 250,680 |
| 16/09/26 | 0.54 | 0.547 | 0.498 | 0.498 | 164,687 |
| 15/09/26 | 0.48 | 0.5489 | 0.4785 | 0.529 | 120,200 |
| 14/09/26 | 0.4521 | 0.5179 | 0.4521 | 0.4841 | 111,313 |
| 11/09/26 | 0.4467 | 0.49 | 0.4467 | 0.4602 | 261,833 |
| 10/09/26 | 0.475 | 0.5082 | 0.4337 | 0.441 | 257,504 |
| 09/09/26 | 0.509 | 0.51 | 0.4818 | 0.4937 | 49,050 |
|
|
||||
|
|
||||
|
|